Cannabis and Vaping: Peer-Reviewed Research Consensus

15 studies analyzedLast updated March 7, 2026

Overview

Research on cannabis and vaping is limited — only 15 studies are available in the literature (2024–2026). Conclusions should be considered preliminary and may evolve as more research is conducted. Key findings with strong support include: among 157,500 california students, 75% had heard about vaping lung injuries but only 11% correctly identified cannabis vapes as the cause — most blamed nicotine, highlighting a critical gap in health communication. However, several findings remain debated, and the evidence is not uniform across all areas. Given the small evidence base, readers should interpret these results cautiously.

What the Research Shows

Findings supported by multiple peer-reviewed studies. Stronger evidence means more consistency across study types.

Among 157,500 California students, 75% had heard about vaping lung injuries but only 11% correctly identified cannabis vapes as the cause — most blamed nicotine, highlighting a critical gap in health communication

Moderate Evidence
1 study|Based on limited number of strong-evidence studies.

Where Scientists Disagree

Areas where research shows conflicting results or ongoing scientific debate.

Lab analysis of vaping products from 16 California high schools found 90% of disposable vape pens contained THC or CBD, and some nicotine labels were inaccurate

Moderate Evidence
4 studies|Products were collected from a convenience sample of 16 California schools during a two-week period in 2019, limiting generalizability. Self-reported product labels may not reflect what students knew

Review warns that the 2018 Farm Bill enabled an unregulated market for CBD-derived synthetic cannabinoids, including compounds more potent than THC and acetate esters linked to lung injuries

Moderate Evidence
4 studies|The review relies on limited available research, as most CBD-derived cannabinoids have never been formally studied. Market composition changes rapidly, potentially outpacing the review. The actual pre

Risk assessment of metals in Canadian legal cannabis products found low health risk even for daily heavy users, validating the Cannabis Act's quality control framework

Moderate Evidence
4 studies|Risk assessment is limited to the legal regulated market and does not address illicit products. Uncertainties in exposure characterization for cannabis inhalation (varying amounts consumed, depth of i

Survey of 2,476 high schoolers found cannabis vaping more prevalent among LGB+, Hispanic, and multiethnic adolescents, with dual nicotine-cannabis vapers showing the worst mental health and behavioral profiles

Moderate Evidence
4 studies|Cross-sectional design. Two states only (CO, OH). Self-reported vaping. Cannot establish causation between vaping and psychosocial factors. Low prevalence of cannabis-only vaping limits statistical po

What We Still Don't Know

  • Sex-specific differences in this area remain understudied.
  • With only 15 studies, this remains an emerging research area where conclusions should be considered preliminary.
  • Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
  • Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.

Evidence Breakdown

Distribution of study types in this research area. Higher-tier evidence (meta-analyses, RCTs) provides stronger conclusions.

Observational & Cohort(Tier 3-4)
10 (67%)
Reviews & Scoping(Tier 4)
3 (20%)
Other
2 (13%)

Key Studies

The most impactful research in this area.

Heavy Metals in Canadian Legal Cannabis Products Pose Low Health Risk Under Current Regulations

Heavy metals in cannabis are a recognized consumer concern, especially for inhaled products. This systematic risk assessment provides the first comprehensive evaluation showing that Canada's regulatory framework -- with good production practices and pharmacopoeial impurity limits -- is effectively c

2025

Most Teens Heard About the Vaping Lung Injury Outbreak — But Most Blamed Nicotine, Not Cannabis

The EVALI crisis killed 68 people, primarily from vitamin E acetate in illicit cannabis vapes. But the public health message was garbled — most teens think nicotine vapes were the problem. This misinformation may cause teens to avoid less-harmful nicotine vapes while underestimating risks of illicit

2025

The 2018 Farm Bill Created an Unregulated Market for Potent Synthetic Cannabinoids Made From CBD

Millions of Americans are consuming CBD-derived cannabinoids that may be more potent than THC, contain unknown reaction byproducts, and include chemical structures linked to serious lung injuries. This represents a regulatory blind spot created by the Farm Bill's hemp legalization that could become

2024

How You Use Cannabis Changes How It Feels: Bongs, Vapes, and Edibles Compared

How you consume cannabis matters more than most people realize — different methods produce different subjective experiences that predict continued use patterns and potential harm.

2026

Cannabis Vaping Linked to Anxiety and Depression Symptoms in Teens

Cannabis vaping is increasingly common among teens. This large national study suggests different cannabinoids may have different mental health associations — THC linking to depression and CBD to anxiety — which challenges simple narratives about either compound.

2026

Three Distinct Daily Substance Use Patterns Emerge Among Young Adult Vapers

Understanding daily substance use patterns reveals that vaping, cannabis, and combustible tobacco use are interconnected — interventions targeting one substance should consider these overlapping patterns.

2026

Research Timeline

How our understanding of this topic has evolved.

2020–present

15 studies published. Includes 1 strong-evidence studies.

About This Consensus

This consensus synthesizes 15 peer-reviewed studies: 10 observational studies (67%), 3 reviews (20%), 2 other study types (13%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.

This page synthesizes findings from 15 peer-reviewed studies. It is not medical advice. Always consult a healthcare provider for personal health decisions.